Delivery Order SPE2DB25D3202-SPE2DB25FTBDN
Award Date 8/14/25
Potential Completion Date 8/15/25
Potential Value $8.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,227.78 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This non-competitive delivery order is structured as a firm fixed-price contract with a completion deadline of August 6, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Contrave is a prescription weight-management medication combining naltrexone and bupropion, supporting the...
- The Defense Logistics Agency awarded a delivery order valued at $22,397.23 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,979.14 delivery order to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract, with performance to be conducted at the contractor's facility in Conshohocken, Pennsylvania. The award is classified as a child contract, indicating it derives from a larger contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,515.09 delivery order for Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $1,358.10 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units). The contract, awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the vendor's facility in Conshohocken, Pennsylvania. This award is issued as a child order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $6,406.51 to AmerisourceBergen Drug Corp for Contrave ER 8-90 mg tablets (120 count) on August 1, 2025, with completion targeted for August 4, 2025. This competitively awarded, firm fixed-price delivery order utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count packages). The contract, valued at $2,533.30, represents a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of August 19, 2025. This award is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,070.95 on July 29, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. As a delivery order, this award is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,713.86 to AmerisourceBergen Drug Corp for the supply of Contrave ER 8-90 mg tablets (120-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. Performance will occur at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,563.06 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 120 tablets of the medication CONTRAVE ER 8-90 MG. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...